The human cytomegalovirus (HCMV) IE2p86 protein is pivotal for coordinated regulation of viral gene expression. Besides functioning as a promiscuous transactivator, IE2p86 is also known to negatively regulate its own transcription. This occurs via direct binding of IE2p86 to a 14-bp palindromic DNA element located between the TATA box and the transcription start site of the major immediate-early promoter (MIEP), which is referred to as the cis repression signal (CRS). However, the exact mechanism of IE2p86-based autorepression is still unclear. By testing a series of IE2p86 mutants in transient expression assays, we found that not only did a DNA binding-deficient mutant of IE2p86 fail to repress the MIEP, but SUMOylation-negative mutants also failed to repress it. This finding was further supported by infection studies with primary fibroblasts harbouring a MIEP-driven transgene as a reporter. Here, we observed that a recombinant HCMV expressing SUMOylation-negative IE2p86 was defective in transgene downregulation, in contrast to wild-type HCMV. Interestingly, however, a double-mutant virus in which both the SUMO acceptor sites and the SUMO interaction motif (SIM) of IE2p86 were inactivated regained the ability to silence the MIEP. This correlated with increased expression levels of the IE2 isoforms IE2p40 and IE2p60, suggesting that these late proteins may contribute to MIEP suppression, thus compensating for the loss of IE2p86 SUMOylation. In summary, our results show that autorepression of the MIEP is not only regulated by late isoforms of IE2, but also depends on posttranslational SUMO modification, revealing a novel mechanism to fine-tune the expression of this important viral gene region.
INTRODUCTION
Human cytomegalovirus (HCMV), the prototypical member of the family Betaherpesviridae, is a widespread human pathogen, with a high percentage of the population being infected and carrying the virus in a latent state. Generally, HCMV has low pathogenicity when infecting healthy individuals. In contrast, primary infection or reactivation in immunocompromised individuals can be associated with serious pathology or mortality [1] .
Efficient productive infection with HCMV depends on the temporally regulated expression of viral genes in a cascade fashion designated as immediate-early (IE), early and late phase [2, 3] . IE gene expression is mainly driven by a very strong and complex regulatory element known as the enhancer-containing major IE promoter (MIEP), resulting in the synthesis of the important viral regulatory proteins IE1p72 and IE2p86 [4] . These viral gene products have been implicated in playing a crucial role in the coordinated regulation of viral gene expression. While IE1 deletion viruses exhibit a growth defect, especially under low multiplicity of infection (m.o.i.) conditions [5] [6] [7] , IE2p86 is strictly required for HCMV replication, as even small sequence deletions result in nonviable virus [8, 9] . Thus, IE2p86 is thought to be the key viral transactivator, as it is absolutely essential for lytic infection and the progression of the replicative cycle from the IE to the early phase.
At the same time IE2p86 also has the capability to negatively autoregulate its own transcription. This occurs through direct binding of IE2p86 to a 14-bp palindromic sequence element, designated as the cis repression signal (CRS), which is located between the TATA box and the transcription start site of the MIEP [10] [11] [12] [13] [14] [15] . In vitro experiments suggest that although IE2p86-mediated autorepression does not lead to changes in the binding of basal transcription factors to the MIEP [16] , it seems to selectively interfere with assembly of the RNA polymerase II preinitiation complex at the promoter [17] . Furthermore, infection studies have shown that IE2p86-induced promoter shutdown at late times of infection correlates with a repressive chromatin structure around the MIEP. This is presumably accomplished through the recruitment of chromatin remodelling enzymes that are associated with transcriptional repression, such as the histone deacetylase HDAC1 or the histone methyltransferases G9a and Suvar(3-9)H1, with which IE2p86 physically and functionally interacts [18] . Finally, the 40 kDa variant of IE2 (IE2p40), which is expressed with late kinetics, has also been discussed as contributing to the transcriptional repression of the IE gene locus, as it has the capacity to downregulate the MIEP in transient transfection assays as well as in infected cells [19, 20] . However, despite all these findings, the exact mechanism of IE2-based autorepression has not yet been entirely clarified.
It is becoming increasingly clear that the distinct regulatory functions of IE2p86 are coordinated by posttranslational modifications of the viral effector protein, such as SUMOylation. The cellular SUMOylation pathway, which is largely analogous to the ubiquitin modification pathway, influences many aspects of protein function, including protein-protein interactions [21] . For IE2p86, two SUMO acceptor sites have been mapped in previous studies at lysine residues K175 and K180, which appear to be used alternatively for the covalent attachment of SUMO [22, 23] . In transient transfection experiments, abrogation of IE2p86 SUMOylation has been shown to strongly reduce the capacity of IE2p86 to transactivate diverse cellular and viral promoters [22, 23] . In accordance with this, recombinant viruses expressing SUMOylation-negative IE2p86 exhibit a pronounced replication defect, confirming the importance of IE2p86 SUMOylation for the in vivo function of this viral regulatory protein [24] . Moreover, IE2p86 also has the ability to non-covalently interact with SUMO through a motif referred to as the SUMO interaction motif (SIM). This SIM is necessary for the efficient SUMOylation of IE2p86, as well as its transactivation activity through the recruitment of other SUMO-modified transcription cofactors, such as TAF12, thereby promoting viral growth [24, 25] .
Here, we report that the covalent coupling of SUMO is not only of relevance for the transactivator function of IE2p86, but also contributes to its ability to negatively autoregulate the MIEP. We provide evidence that SUMOylated IE2p86 strongly represses the MIEP in vitro and in vivo, which highlights the importance of this posttranslational modification for regulating the differential effector functions of IE2p86. In addition, our results further support the notion of the late isoforms IE2p40 and/or IE2p60 being involved in MIEP autoregulation, thus demonstrating the complex regulatory mechanisms that control expression of the IE gene locus during the course of infection.
RESULTS

Determinants of IE2p86-based autorepression
The fact that IE2p86 represses the MIEP (CMV promoter) can be monitored in transient transfection experiments (Fig. 1) . In Fig. 1(a) , HEK293T cells were cotransfected with a lentiviral pLKO-based plasmid where expression of the major ND10 factor PML (isoform VI) is driven by the CMV promoter, along with increasing amounts of the transcriptional regulator IE2p86 (Fig. 1a, second panel) . As expected, this resulted in the dose-dependent downregulation of PMLVI expression by IE2p86 (Fig. 1a, first panel) . In contrast to that, suppression of PML expression could be abolished by transfecting a previously described mutant of IE2p86 that exhibits a defect in DNA binding due to amino acid substitutions in a putative zinc finger motif located within the C-terminus of IE2 (IE2mut) [14] (Fig. 1b) . As can be seen in Fig. 1(b) , IE2mut failed to shut down PML expression compared to WT IE2p86 (Fig. 1b, first panel,  compare lanes 3 and 4) , since DNA binding of IE2p86 to the CRS element is a prerequisite for repression of the MIEP. As a consequence of this, inhibition of PML transcription by IE2p86 could also be abrogated by deleting the entire CRS element from the CMV promoter of plasmid pLKO/CMV-PMLIV (Fig. 1c) . As indicated in Fig. 1(c) , construct pLKO/CMV-DCRS, which lacked the CRS, could no longer be silenced by IE2p86, in contrast to the original pLKO/CMV vector (Fig. 1c, first IE2p86 inhibits expression from diverse lentiviral vectors Due to its extraordinary strength, the CMV promoter is commonly used in many eukaryotic expression vectors, such as pcDNA3-derived constructs. Further, the vast majority of commercially available lentiviral plasmids harbour the CMV promoter in order to ensure efficient target gene expression in transduced cells. However, as indicated in Fig. 2(a) , in contrast to pcDNA3-based constructs, which contain a MIEP without the CRS element, and which are In subsequent transfection experiments, we were able to exemplarily demonstrate sensitivity to IE2p86-based transcriptional suppression of the following CMV promotercontaining lentiviral plasmids: pINDUCER20 (Fig. 2b) , pLenti6/V5-D-TOPO (Fig. 2c ) and pLenti6.4/R4R2/V5-D-TOPO (Fig. 2d) . In this way, the expression of diverse viral (Fig. 2b , HCMV IE1p72 protein) as well as cellular target genes (Fig. 2c , mCherry-tagged PMLVI; Fig. 2d , Sp100 isoform B) was negatively affected by IE2p86. As already evident from Fig. 1(c) , one way to circumvent this problem is to delete the CRS element from the MIEP, as this prevented IE2p86-induced promoter shutdown (see Fig. 1c ). An alternative strategy would be the use of lentiviral plasmids with promoter elements that are known to be not negatively affected by IE2p86, such as the cellular EF-1a promoter ( HCMV infection leads to a shutdown of CMV promoter-driven transgene expression In order to be able to unravel novel aspects of IE2p86-based MIEP regulation in the context of viral infection, we first generated primary fibroblasts with a CMV promoter-driven transgene as a reporter system. To this end, HFF cells were lentivirally transduced with the pLKO-PMLIV vector harbouring the CMV/MIEP (including the CRS element) or the cellular EF-1a promoter. The latter served as a negative control, as target gene expression should remain unaffected by IE2p86. Successful gene delivery was verified via Western blotting by either applying an anti-FLAG antibody for specific detection of lentivirally transferred FLAG-PMLIV (Fig. 3a, first panel) or the polyclonal antiserum A301-168, which exclusively detects PML isoforms I and IV (Fig. 3a , second panel). Interestingly, the detection of PML with A301-106 allowed us to discriminate between endogenous and exogenous PMLIV (endo. and exog. PMLIV) as the lentivirally introduced PML due to its FLAG tag showed a slight mobility shift (Fig. 3a , second panel). Infection of these cells with wild-type HCMV strain AD169 revealed that transgene expression based on the pLKO/CMV . PML was visualized using the same antibodies as specified in (a). Detection of IE1 and MCP expression served as an infection control, while beta-actin was included as internal loading control. Abbreviations: F, FLAG; S, SUMO.
construct was indeed effectively downregulated during the course of HCMV replication, as FLAG-PMLIV was no longer detectable starting at 48 h p.i. (Fig. 3b , first panel on the left). Moreover, we were able to demonstrate that only exogenous PMLIV expression was negatively affected by HCMV as endogenous PMLIV, in parallel, was upregulated as a consequence of HCMV infection (Fig. 3b, second panel on  the left) . By contrast, FLAG-PMLIV expressed from the pLKO/EF-1a promoter was resistant against HCMV-triggered shutdown of target gene expression (Fig. 3b , first panel on the right), while exogenous PMLIV was readily detectable throughout the entire replication cycle, and was comparable to endogenous PMLIV (Fig. 3b , second panel on the right). In conclusion, these findings highlight the importance of an appropriate choice of promoter for retroviral transduction experiments in order to preclude a loss of transgene expression following HCMV infection.
SUMOylation of IE2p86 is a prerequisite for negative regulation of the MIEP
In an attempt to better understand the molecular mechanisms by which IE2p86 facilitates its well-established role in autorepression, we screened a series of IE2p86 mutants for their ability to suppress the CMV promoter in vitro. In transfection assays using the expression vector pCMV6-XL4, which contains a MIEP including CRS, we found that a SUMOylation-deficient mutant of IE2p86 (IE2-SUMOmut) was as defective in negatively regulating the expression of the ND10-related host cell factor PLZF as our positive control, the DNA-binding mutant IE2mut (Fig. 4a) . Thus, by mutating the SUMO acceptor lysine residues K175 and K180 of IE2p86 to arginine, which abrogates its posttranslational SUMO modification (Fig. 4a, second panel, lane 4) , promoter shutdown could be abolished (Fig. 4a, first panel,  lane 4 ). This indicates that SUMOylation of IE2p86 is necessary for autorepression of the MIEP. In order to address the in vivo relevance of this finding, we next analysed the role of IE2-SUMOmut in the viral context. For this, we infected the lentivirally transduced pLKO/CMV-PMLIV cells with wildtype HCMV strain AD169 or a recombinant virus expressing SUMOylation-negative IE2p86 (AD169DS). As is evident from Fig. 4(b) , FLAG-PMLIV transgene expression based on the CMV promoter construct was again effectively downregulated following infection with the wild-type virus (Fig. 4b, first and second panels, lane 2) . However, in contrast to that, the AD169DS mutant virus turned out to be defective in negative autoregulation of the CMV promoter, as it was no longer able to shut down PMLIV transgene expression (Fig. 4b, first and second panels, lane 4) . As expected, we found a strong upregulation of FLAG-PMLIV compared to mock-infected cells in case IE2p86 lost its ability to silence the pLKO/CMV construct (Fig. 4b, first and  second panels, compare lanes 3 and 4) . Hence, our data show that SUMOylation of IE2p86 is absolutely essential for autorepression of the CMV promoter in vitro as well as in vivo.
Late isoforms of IE2 contribute to MIEP repression
In addition to the two covalent SUMO attachment sites, the IE2p86 protein contains a SIM motif, which enables IE2p86 to interact non-covalently with SUMO and other SUMOylated proteins [24, 25] . Next, we infected the HFF pLKO/ CMV-PMLIV cells with a recombinant virus where, in addition to the SUMO acceptor sites, the SIM motif was also inactivated (AD169DSM2) (Fig. 4b) . Interestingly, this double-mutant virus regained the ability to negatively regulate the MIEP. As with infection with wild-type AD169, FLAG-PML target gene expression was no longer detectable 96 h p.i. with AD169DSM2 (Fig. 4b, first and second panels, compare lanes 2 and 6). This was remarkable, as IE2p86 expressed from AD169DSM2 was likewise SUMOylation-negative, as upon infection with the single-mutant virus AD169DS (Fig. 4b, third panel, compare lanes 4 and 6 to lane 2) . In addition, transient transfection experiments confirmed that the IE2p86 SUMO-SIM double-mutant (SUMO+SIMmut), in contrast to wild-type IE2p86 (IE2) or a SIM-mutant only (SIMmut), was defective in negatively regulating the MIEP, as it showed the same phenotype as the SUMO mutant (SUMOmut) (Fig. 4c , first panel, compare lanes 8 and 10 to lanes 7 and 9). Consequently, introduction of the additional SIM mutation into SUMOylation-negative IE2p86 (SUMO+-SIMmut) did not result in regaining of the repressor function of the viral effector protein in vitro (Fig. 4c) , which was in clear contrast to the infection setting (AD169DSM2) (Fig. 4b) . This already suggested that following AD169DSM2 infection, other viral proteins independent of IE2p86 had to be responsible for the observed PMLIV transgene downregulation (Fig. 4b) . In fact, we could identify a further gain of function of the double-mutant AD169DSM2 compared to AD169DS. In addition to full-length IE2p86, two smaller variants of 40 kDa (IE2p40) and 60 kDa (IE2p60) are expressed from the IE2 gene at late times of infection with WT AD169 (Fig. 4b, third panel, lane 2) . Previous findings in the literature have already indicated the involvement of the small IE2 isoforms, especially IE2p40, in MIEP autorepression [19, 20] . Intriguingly, while only very little IE2p40 and no IE2p60 at all were detectable upon infection with AD169DS (Fig. 4b,  third panel, lane 4) , AD169DSM2 regained the ability to express both isoforms efficiently (Fig. 4b, third panel, lane 6 ). This may compensate for the loss of IE2p86 SUMOylation with regard to CMV promoter inhibition in the context of viral infection. Thus, our results further support the assumption that in addition to full-length IE2p86, the late isoforms IE2p40 and/or IE2p60 also contribute to negative autoregulation of the MIEP.
DISCUSSION
While IE2p86 is generally known to function as a strong transactivator of viral as well as cellular gene expression, it also has the capacity to negatively autoregulate transcription driven by the MIEP [26] . In this regard, IE2p86 has been shown to directly bind to a cis-acting element of the MIEP referred to as the cis-repression signal (CRS), thereby blocking transcription initiation by preventing binding of the RNA polymerase II to the transcription start site [26] . In accordance with this, we constantly observed an IE2p86-induced repression of diverse CMV promoter-containing expression plasmids in transient transfection assays (see Figs 1 and 2 ). As expected, this suppression was dependent on the DNA-binding activity of IE2p86, as well as the presence of the CRS element within the MIEP (see Fig. 1b, c) . However, although autoregulation of the HCMV MIEP by IE2p86 is well established, the exact mechanistic basis for this is nonetheless unclear.
Our results now show that IE2p86-based shutdown of the MIEP is dependent on the covalent attachment of SUMO, as only SUMOylated IE2p86 was capable of strong silencing of the CMV promoter in vitro as well as in vivo (see Fig. 4 ). When unravelling how SUMOylation of IE2p86 contributes to negative autoregulation, it is worth noting that SUMOylation is not required for the ability of IE2p86 to bind to the CMV promoter, as it has previously been demonstrated by DNase I protection and gel retardation experiments that prokaryotically expressed IE2p86 binds efficiently to the CRS element [12] . This leads to the overall assumption that binding of IE2p86 to the CRS alone is not sufficient for negative autoregulation of the CMV promoter. This hypothesis is in accordance with previous findings by Reeves and colleagues [18] . They were able to show that autorepression by IE2p86 during infection correlates with an induction of a repressive chromatin structure around the MIEP at late stages of the viral life cycle [18] . This likely results from physical and functional interactions between IE2p86 and chromatin-remodelling enzymes, which are normally associated with transcriptional repression of cellular promoters, such as the histone deacetylase HDAC1 or the histone methyltransferases (HMTs) G9a and Suvar(3-9)H1 (SUV39H1) [18] . Interestingly, in the host cell context these HMTs have already been shown to be regulated in a SUMOylation-dependent manner. Together with SETDB1 and GLP, G9a and SUV39H1 are part of an H3K9 methylation multimeric complex that is recruited to the DNA by the cellular factor KAP-1 [27] . However, this only occurs if KAP-1 is posttranslationally modified by SUMO [28, 29] . De-SUMOylation of KAP-1 consequently results in a release of the complex, which is followed by a decondensation of the chromatin. Thus, these findings give rise to the hypothesis that IE2p86 needs to be SUMOylated in order to be able to recruit these heterochromatin-building factors to the MIEP for negative autoregulation.
This assumption is further supported by accumulating evidence in the literature that SUMO modification is an important control in transcriptional regulation in general [30] . With an increasing number of SUMOylated transcription factors and cofactors being identified, in most cases SUMO modification appears to repress the activity of targeted transcriptional regulators by altering, for instance, their interaction properties [30] . However, in addition to SUMO's role in transcriptional repression, SUMOylation has also been shown to be involved in transcriptional activation in a growing number of cases [31] . Indeed, in the case of IE2p86 it was demonstrated that the transactivator function of the viral effector protein is also regulated in a SUMO-dependent manner, as the abrogation of IE2p86 SUMOylation results in a strong reduction of its transactivation capacity [22] [23] [24] . Hence, covalent attachment of SUMO seems to be important for transcriptional repression as well as activation mediated by IE2p86. In this context, it is interesting to note that similar observations have been made for the Krüppel-like zinc finger DNA-binding factor Ikaros, which plays a key role in lymphocyte development and homeostasis by both stimulating and repressing gene expression at the same time [32] . Here, Gómez-del Arco and colleagues identified two SUMOylation sites on Ikaros, whose simultaneous modification results in a loss of Ikaros's repressor function [32] . Interestingly, two SUMO acceptor sites have also been mapped for IE2p86 at lysine residues K175 and K180 [22, 23] . Thus, it is tempting to speculate that the alternative use of K175 and K180 may be responsible for modulating the differential transcriptional effector functions of IE2p86.
Further, additional isoforms of 40 kDa (IE2p40) and 60 kDa (IE2p60) are expressed from the IE2 gene at late times postinfection, which are assumed to contribute to regulation of the MIEP. In particular, IE2p40, which has been more extensively characterized than IE2p60, is suggested to downregulate IE gene expression in transient transfection assays as well as in infected cells [19, 20] . Our data now further support the assumption that the small IE2 isoforms contribute to MIEP shutdown at late times of the viral replication cycle (see Fig. 4 ). This was inferred from infection experiments with an IE2p86 SUMO+SIM double-mutant virus AD169DSM2 that, in contrast to the IE2p86 SUMO single-mutant AD169DS, regained the ability to shut down a CMV promoter-driven reporter construct (see Fig. 4b ). Since transient transfection experiments indicated that IE2p86 SUMO+SIMmut is defective in CMV promoter repression, we assume that other viral proteins account for the loss of target gene expression during infection with AD169DSM2 (see Fig. 4c ). Indeed, we observed that the AD169DSM2 virus regained the ability to efficiently express the late variants of IE2 compared to AD169DS, which failed to do so (see Fig. 4b ). Of note, the viruses used for the infection experiment of Fig. 4 were titrated to result in equal expression levels of IE2p86, thus facilitating the comparison of IE2p40 and IE2p60 expression. Therefore, it is tempting to speculate that following infection with the double-mutant virus, IE2p40 and/or IE2p60 compensate for the lack of IE2p86 SUMOylation in CMV promoter regulation. In this regard, the single-mutant AD169DS exhibits two defects, since both determinants of MIEP suppression -SUMOylation of full-length IE2p86 as well as expression of the late IE2 isoforms -are inactivated. Thus, the recombinant AD169DS virus represents an attractive tool with which to study further aspects of CMV promoter regulation in the context of viral infection.
Finally, our experiments highlight another important point that is of major relevance for HCMV research. Due to its high basal activity, the CMV promoter can be found in a wide variety of expression vectors. In particular, lentiviral vectors, which are widely used for protein overexpression studies during viral infection, as HCMV-permissive primary cells are hard to transfect, frequently contain the MIEP including the CRS element. However, such constructs are subject to IE2p86-mediated silencing (see Fig. 2 ), so that in this case HCMV infection leads to a severe shutdown of lentiviral transgene expression (see Fig. 3 ). Therefore, the selection of an appropriate promoter is of major importance in order to prevent loss of target gene expression following HCMV infection.
METHODS
Oligonucleotides and plasmid constructs
The oligonucleotide primers used for this study were purchased from Biomers GmbH (Ulm, Germany) and are listed in Table 1 . The plasmids coding for WT IE2p86 (pHM134), GFP-tagged versions of WT IE2p86 (pHM990) as well as the IE2p86 SUMOylation and SIM single-or doublemutants SUMOmut (pHM1008), SIMmut (pHM2716) and SUMO+SIMmut (pHM2717), were described previously [24, 33] . The pcDNA3.1-based vector encoding myc-tagged PML isoform VI (pHM2236) as well as the lentiviral vectors coding for the mCherry-tagged version of PMLVI (pLenti6/ V5-D-TOPO containing the CMV/MIEP; pHM2421) and for IE1 (pINDUCER20-based lentiviral vector harbouring the CMV/MIEP) were constructed as mentioned elsewhere [33, 34] . The PLZF cDNA expression vector pCMV6-XL4 was purchased from Origene (Origene Technologies, MD, USA). Lentivirus vector plasmids expressing PML isoforms IV and VI (pLKO/CMV-PMLIV and pLKO/CMV-PMLVI) harbouring the CMV/MIEP with the CRS element, were kindly provided by Dr Roger Everett (Glasgow, UK) [35] . Derivatives of pLKO-PMLIV in which the CMV/MIEP was either exchanged by the cellular EF-1a promoter (pHM4188) or a CMV/MIEP with a deletion of the CRS element (CMV/MIEP-DCRS; pHM4232) were generated by PCR amplification of the respective promoters using the Life Technologies vectors (Darmstadt, Germany) pENTR-5-EF1a or pcDNA3.1 (containing CMV/MIEP that lacks the CRS element) as templates, along with primer pairs 5¢EF1alpha-NdeI and 3¢EF1alpha-PacI or 5¢MIEP/ pcDNA3-NdeI and 3¢MIEP/pcDNA3-PacI, respectively. The lentiviral constructs coding for FLAG-Sp100B, where expression is driven by either the cellular EF-1a promoter (pHM3425) or the CMV/MIEP (pHM3429), were generated using the pLenti6.4/R4R2/V5-DEST MultiSite Gateway vector kit from Life Technologies (Darmstadt, Germany). According to manufacturer's instructions, an initial BP recombination reaction was performed to introduce the FLAG-Sp100B sequence, which was amplified in a PCR reaction with primers 5¢attB1_FLAG and 3¢Sp100B-attB2, along with pHM3418 as the template, into pDONR221 to obtain pHM3422. The eukaryotic expression plasmid pHM3418 coding for FLAG-Sp100B was constructed via PCR amplification with primers 5¢Sp100-EcoRV and 3¢Sp100B-Not1, with pF884 as the template (pSG5-Sp100B, kindly provided by G. G. Maul, Philadelphia, USA), followed by insertion into pHM971 (pcDNA3.1-FLAG) [22] . A three-plasmid LR recombination reaction including pHM3422, the Gateway destination clone pLenti6.4/R4R2/ V5-DEST, as well as the respective Gateway promoter entry vectors pENTR-5-CMV or pENTR-5-EF1a, finally gave rise to the lentiviral vectors pHM3425 (EF-1a/FLAG-Sp100B) and pHM3429 (CMV-MIEP/FLAG-Sp100B), respectively. The expression plasmid pHM4163 coding for the DNA binding-deficient IE2p86 mutant (IE2mut) was generated via site-directed mutagenesis, using the primer pair delDNAbinIE2-5¢ and delDNAbinIE2-3¢, resulting in the substitution of two histidine residues (amino acids 446 and 452 of IE2) to leucines. The generation of GFP-tagged IE2mut (pHM2626) has been described previously [36] . The integrity of all newly generated plasmids was confirmed by automated DNA sequence analysis.
Cells and viruses
HEK293T cells were cultivated in Dulbecco's minimal essential medium (DMEM) containing 10 % foetal calf serum (Gibco, Thermo Fisher Scientific, Waltham, MA, USA). Primary human foreskin fibroblasts (HFFs) were maintained in Eagle's minimal essential medium (MEM) supplemented with 5 % foetal calf serum (Gibco, Thermo Fisher Scientific, Waltham, MA, USA). Infection experiments were performed with the HCMV laboratory strain AD169. The recombinant viruses AD169DS and AD169DSM2 were described previously [24] . Viral stocks were titrated via IE1p72 fluorescence [37] . For this purpose, HFFs were infected with various dilutions of virus stocks. After 24 h of incubation, cells were fixed and stained with monoclonal antibody p63-27 directed against IE1p72 [38] . Subsequently, the number of IE1-positive cells was determined and used to calculate viral titres, expressed as IE protein-forming units (IEUs).
Lentivirus transduction and selection of stably transduced cells For the generation of HFF cells stably expressing a FLAGtagged version of PML isoform IV, replication-deficient lentiviruses were generated using pLKO-based expression vectors that contained either the CMV/MIEP or the cellular EF-1 alpha promoter. For this purpose, HEK293T cells seeded in 10 cm dishes (5Â10 6 cells/dish) were cotransfected with the respective pLKO vectors, together with packaging plasmids pLP1, pLP2 and pLP/VSV-G, using the Lipofectamine 2000 reagent (Invitrogen, Karlsruhe, Germany). Viral 
Antibodies
The polyclonal antisera raised against exon 5 of IE2p86 (referred to as anti-pHM178) or pUL84 of HCMV were generated by immunizing rabbits with the respective prokaryotically expressed proteins. MAb-UL44 BS 510 against the replication protein UL44 and MAb-MCP 28-4 against the major capsid protein MCP were kindly provided by William Britt (University of Birmingham, AL, USA). Monoclonal antibody (MAb) p63-27, which recognizes IE1, has been described elsewhere [38] . For the detection of FLAG-tagged versions of PML the monoclonal antibody MAb-FLAG M2 (Merck, Darmstadt, Germany) was utilized. Alternatively, the polyclonal antiserum A301-168 from Bethyl Laboratories, Inc. (Montgomery, TX, USA) was applied, which specifically recognizes PML isoforms I and IV only. The expression of mCh-PML was detected by using the rabbit polyclonal antibody H-238 (Santa Cruz Biotechnology, Santa Cruz, CA, USA). Sp100 was visualized by applying the rabbit polyclonal antiserum GH3 (a kind gift from Hans Will, Heinrich Pette Institute for Experimental Virology and Immunology, University of Hamburg, Hamburg, Germany). For the detection of the ND10-related factor PLZF the monoclonal antibody MAB2944 (R&D Systems, Wiesbaden, Germany) was utilized. Monoclonal antibody AC-15, which recognizes beta-actin, was purchased from Merck (Darmstadt, Germany). Horseradish peroxidase-conjugated anti-mouse and anti-rabbit secondary antibodies for Western blot analysis were obtained from Dianova (Hamburg, Germany).
Immunoblotting
Lysates from infected HFF or transfected HEK293T cells were prepared in a sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) loading buffer, and boiled at 95 C for 10 min. Proteins were separated by SDS-PAGE on 8 to 12.5% polyacrylamide gels and transferred onto nitrocellulose membranes (GE Healthcare, Munich, Germany), with this being followed by chemiluminescence detection according to the manufacturer's protocol (ECL Western blotting detection kit; Amersham Pharmacia Biotech Europe, Freiburg, Germany).
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